Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

May 18, 2017
Relmada Therapeutics Announces Settlement of Legal Action with Laidlaw & Company

NEW YORK, May 18, 2017 /PRNewswire/ --┬áRelmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, and Laidlaw & Company (UK) Ltd. ("Laidlaw"), today announced final disposition of all claims and counterclaims in all legal proceedings related to Relmada Therapeutics, Inc. v. Laidlaw & Company… Read More ┬╗

More Press Releases

Twitter

View All Tweets